Answers are grounded in this paper and cite their sources.
Case report identifies a SH3PXD2A::HTRA1 fusion in a plexiform Wagner-Meissner schwannoma of the finger, suggesting that these tumors share a molecular driver with serpentine palisading schwannomas.
BACKGROUND: A peripheral nerve sheath tumour composed predominantly of Wagner-Meissner (W-M) bodies is typically regarded as a variant of schwannoma and has been considered rare. Interestingly, a SH3PXD2A::HTRA1 fusion was found which is described in schwannomas with a so-called "serpentine" palisading pattern comprising short palisades of Schwann cells. METHODS: We describe a case of plexiform W-M schwannoma with a SH3PXD2A::HTRA1 fusion demonstrated on RNA-based next generation sequencing and review the relevant histological, immunohistochemical and molecular findings and discuss differential diagnoses. RESULTS: The lesion arose in the distal volar pulp of the right middle finger in a 37-year-old female. It had a plexiform architecture and was composed predominantly of densely packed, repetitive Wagner-Meissner bodies which expressed S100, SOX10, Calretinin and CD56, with intervening S100, SOX10, CD34 and patchy EMA staining. It showed no NF1 expression. A SH3PXD2A::HTRA1 fusion was present. CONCLUSIONS: The case presented suggests that so-called W-M schwannomas may be driven by SH3PXD2A::HTRA1 fusions and that W-M bodies in this context correlate with the 'serpentine' palisading pattern described in schwannomas with HTRA1 rearrangements. Analysis of further cases of W-M rich or predominant lesions including schwannoma, neurilemmoma and perhaps even neurotised melanocytic naevi may warrant consideration.
No takes yet. Share an insight, caveat, or question.
Wilsher et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: